切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2026, Vol. 20 ›› Issue (06) : 470 -478. doi: 10.3877/cma.j.issn.1674-0785.2026.06.008

医院管理

胰十二指肠切除术DRG分组优化研究:基于CHS-DRG2.0版HB组与GB组的实证分析
胡云鹤1, 周玉焯1, 汤坚强2,†(), 李爱东3,†()   
  1. 1 100021 北京,国家癌症中心 国家肿瘤临床医学研究中心 中国医学科学院北京协和医学院肿瘤医院医疗保险管理办公室
    2 100021 北京,国家癌症中心 国家肿瘤临床医学研究中心 中国医学科学院北京协和医学院肿瘤医院结直肠外科
    3 100021 北京,国家癌症中心 国家肿瘤临床医学研究中心 中国医学科学院北京协和医学院肿瘤医院院办公室
  • 收稿日期:2026-05-19 出版日期:2026-06-30
  • 通信作者: 汤坚强, 李爱东
  • 基金资助:
    首都卫生管理与政策研究基地开放性课题资助(2024JD09); 由中央高水平医院临床科研业务费资助(LC2024D10)

Optimization of diagnosis-related group classification for pancreaticoduodenectomy: an empirical analysis based on the HB and GB groups of CHS-DRG 2.0

Yunhe Hu1, Yuzhuo Zhou1, Jianqiang Tang2,†(), Aidong Li3,†()   

  1. 1 Insurance Management Office, National Cancer Clinical Research Center, Institute of Cancer Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100021, China
    2 Department of Colorectal Surgery, National Cancer Clinical Research Center, Institute of Cancer Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100021, China
    3 Executive Office National Cancer Center, National Cancer Clinical Research Center, Institute of Cancer Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100021, China
  • Received:2026-05-19 Published:2026-06-30
  • Corresponding author: Jianqiang Tang, Aidong Li
引用本文:

胡云鹤, 周玉焯, 汤坚强, 李爱东. 胰十二指肠切除术DRG分组优化研究:基于CHS-DRG2.0版HB组与GB组的实证分析[J/OL]. 中华临床医师杂志(电子版), 2026, 20(06): 470-478.

Yunhe Hu, Yuzhuo Zhou, Jianqiang Tang, Aidong Li. Optimization of diagnosis-related group classification for pancreaticoduodenectomy: an empirical analysis based on the HB and GB groups of CHS-DRG 2.0[J/OL]. Chinese Journal of Clinicians(Electronic Edition), 2026, 20(06): 470-478.

目的

分析CHS-DRG 2.0版分组方案中胰十二指肠切除术因主要诊断不同而分别纳入HB组与GB组的合理性,比较2组间住院费用与住院天数的差异,并进一步在相同DRG细分层级下进行分层比较,为DRG分组优化提供实证依据。同时从临床诊疗、术式选择、科室绩效及医保支付公平性角度探讨现行分组方式对复杂外科手术管理的潜在影响。

方法

回顾性分析中国医学科学院肿瘤医院2021年1月至2025年10月期间收治的505例胰十二指肠切除术病例,根据纳入的DRG分组分为HB组(432例)和GB组(73例)。采用Mann-Whitney U检验比较2组住院费用与住院天数的差异,并通过Cliff's delta和rank-biserial correlation评估效应量。进一步根据CHS-DRG 2.0版细分组别进行同层级比较,包括HB11 vs GB11、HB13 vs GB29和HB15 vs GB15。采用Kruskal-Wallis检验分析HB组内不同诊断间的住院费用差异。由于GB组样本量较小,尤其是部分同层级亚组病例数有限,分层结果主要用于探索性解释。

结果

2组患者在年龄、性别方面具有可比性(P>0.05)。HB组与GB组住院费用中位数分别为13.54万元(IQR:11.50~16.20)和13.93万元IQR:12.70~16.65)(U=14174,P=0.167),住院天数中位数均为20 d,HB组IQR为14~29 d,GB组IQR为13~25 d(U=14135,P=0.157),差异均无统计学意义。非参数效应量分析显示2组差异为小效应(|δ|<0.147,|r|<0.1)。2组并发症等级构成差异具有统计学意义(χ2=11.063,P=0.0040)。同DRG层级分层比较显示,HB11组与GB11组住院费用差异具有统计学意义[13.66(11.51~17.09)万元 vs 16.77(14.50~19.98)万元,U=864,P=0.0198];HB15组与GB15组住院费用差异亦具有统计学意义[12.77(10.98~14.43)万元 vs 14.20(12.49~16.49)万元,U=1134,P=0.0077];HB13组与GB29组差异无统计学意义(P=0.0964)。HB组内5种主要诊断间的住院费用亦无统计学差异(H=7.12,P=0.130)。

结论

胰十二指肠切除术在HB组与GB组间的资源消耗无显著差异,现行以主要诊断为依据的分组方法未能充分体现“临床过程相似、资源消耗相近”的原则。但同DRG层级分层分析显示部分细分组间仍存在显著费用差异,提示总体比较结果可能受到并发症等级和病例构成差异影响。从临床视角看,分组不合理可能导致胰十二指肠切除术在不同主要诊断路径下支付标准不一,进而影响术式选择的公平性、增加科室绩效管理难度,并对医患沟通中费用预期解释带来挑战。现行以主要诊断为核心的分组方式尚不能充分体现同一高难度术式的资源消耗特征。建议在后续CHS-DRG分组优化中,优先考虑将胰十二指肠切除术纳入MDCA先期分组扩展子目,或在HB组内设立胰十二指肠切除术精细操作亚组。

Objective

This study also aimed to evaluate the rationality of assigning pancreaticoduodenectomy cases to the HB and GB groups under the CHS-DRG 2.0 classification system based on differing principal diagnoses, to compare intergroup differences in hospitalization costs and length of stay (LOS), and to perform stratified analyses at the diagnosis-related group (DRG) subgroup level to inform DRG optimization. A secondary aim was to discuss the potential clinical implications of DRG grouping for surgical decision-making, doctor-patient communication, departmental performance evaluation, and equitable reimbursement for complex surgical procedures.

Methods

A retrospective analysis was conducted on 505 patients who underwent pancreaticoduodenectomy at the Cancer Hospital of Chinese Academy of Medical Sciences from January 2021 to October 2025. The cases were divided into either an HB group (432 cases) or a GB group (73 cases) according to the DRG classification. The Mann-Whitney U test was used to compare hospitalization costs and LOS between the two groups, with effect sizes evaluated using Cliff's delta and rank-biserial correlation. Stratified subgroup comparisons were performed for HB11 vs GB11, HB13 vs GB29, and HB15 vs GB15. The Kruskal-Wallis test was used to analyze the differences in hospitalization costs across principal diagnoses within the HB group. Given the imbalanced sample size, particularly the small number of cases in .certain GB subgroups, subgroup findings are interpreted as exploratory.

Results

The two groups were comparable in age and gender (P>0.05). Median hospitalization costs were 135,400 yuan (IQR: 115,000~162,000) in the HB group and 139,300 yuan (IQR: 127,000~166,500) in the GB group (U=14,174, P=0.167). Median LOS was 20 days in both groups (HB: IQR 14~29 days; GB: IQR 13~25 days; U=14,135, P=0.157). Overall differences were not statistically significant, with non-parametric effect sizes indicating small differences (|δ|<0.147, |r|<0.1). However, the distribution of complication/comorbidity levels differed significantly between groups (χ2=11.063, P=0.0040). Stratified subgroup analyses showed significant differences in hospitalization costs between HB11 and GB11 [136,600 yuan (IQR: 115,100~170,900) vs 167,700 yuan (IQR: 145,000~199,800), U=864, P=0.0198] and between HB15 and GB15 [127,700 yuan (IQR: 109,800-144,300) vs 142,000 yuan (IQR: 124,900-164,900), U=1134, P=0.0077], but no significant difference between HB13 and GB29 (P=0.0964). No statistically significant difference was found among the five principal diagnoses within the HB group (H=7.12, P=0.130).

Conclusion

There is no significant difference in resource consumption between pancreaticoduodenectomy cases in the HB group and the GB group. The current principal diagnosis-based grouping approach fails to fully reflect the principle of "similar clinical processes and similar resource consumption". However, stratified subgroup comparisons revealed significant cost differences in certain subgroups, suggesting that overall comparisons may be confounded by differences in complication levels and case composition. From a clinical perspective, suboptimal grouping may lead to inconsistent payment standards across different principal diagnosis pathways, potentially affecting the fairness of surgical approach selection, complicating departmental performance management, and posing challenges to physician-patient communication regarding cost expectations. It is recommended that pancreaticoduodenectomy be considered for inclusion in an expanded MDCA pre-MDC subgroup, or alternatively, that a refined surgical subgroup specifically for pancreaticoduodenectomy be established within the HB group.

表1 2021年至2025年胰十二指肠切除术的患者基本情况及临床特征
图1 HB组与GB组住院费用分布对比 注:HB为胰、肝切除和/或分流手术;GB为胃、十二指肠大手术
图2 HB组与GB组住院天数分布对比 注:HB为胰、肝切除和/或分流手术;GB为胃、十二指肠大手术
表2 非参数效应量Cliff's delta和rank-biserial correlation分析
表3 同DRG层级下HB组与GB组住院费用比较
图3 HB组所包含的5种诊断的住院费用中位数对比 注:HB为胰、肝切除和/或分流手术
1
国家医疗保障局. 关于印发疾病诊断相关分组(DRG)付费国家试点技术规范和分组方案的通知: 医保办发〔2019〕36号[EB/OL]. [2019-10-16].
2
国家医疗保障局办公室. 关于印发按病组和病种分值付费2.0版分组方案并深入推进相关工作的通知: 医保办发〔2024〕9号[EB/OL]. [2024-7-23].
3
福建省医疗保障局.关于省级公立医疗机构执行CHS-DRG2.0相关政策的通知: 闽医保〔2025〕42号[EB/OL]. [2025-6-11].
4
北京市医疗保障局. 关于开展国家医疗保障按病组(DRG)付费2.0版工作有关问题的通知: 京医保发〔2024〕24号[EB/OL]. [2024-12-27].
5
高红桥, 李宝毅, 马永蔌, 等. 胰十二指肠切除术后出血的危险因素分析及治疗策略 [J]. 中华消化外科杂志, 2022, 21(4): 492-499.
6
吴鹏飞, 张凯, 陈建敏, 等. 胰十二指肠切除术治疗壶腹部周围疾病的临床疗效(附2019例报告) [J]. 中华消化外科杂志, 2022, 21(4): 483-491.
7
吴晶, 赵博雅, 朱玄, 等. DRG分组策略与支付标准界定的国内外比较 [J]. 中国医疗保险, 2021(2): 75-80.
8
沈正超, 王小明. LPD胰肠吻合技术改进及并发症防治策略 [J]. 肝胆外科杂志, 2025, 33(6): 410-412.
9
Hu YH, Yu F, Zhou YZ, et al. Surgical treatment of liver cancer and pancreatic cancer under the China Healthcare Security Diagnosis Related Groups payment system[J]. World J Clin Cases, 2024, 12(21): 4673-4679.
10
侯睿, 刘晓坤, 谭旭彤, 等. 胰腺大手术资源消耗分析及DRG支付方案改进意见 [J]. 中国医药导报, 2024, 21(28): 175-180.
[1] 冯学乾, 王千丹, 张旭. 乳腺叶状肿瘤的诊疗进展与全程管理策略[J/OL]. 中华乳腺病杂志(电子版), 2026, 20(02): 115-119.
[2] 赵晓威, 丁国玉, 冷颜丽, 王红美. 儿童造血干细胞移植后肺功能评估的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2025, 21(06): 611-619.
[3] 彭兵. 联合血管切除重建的腹腔镜胰十二指肠切除术实践与探索[J/OL]. 中华普通外科学文献(电子版), 2026, 20(01): 23-23.
[4] 张锰钢, 刘悦泽, 张太平. 腹腔镜胰十二指肠切除术的关键技术和质量控制[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(03): 210-214.
[5] 杨永君, 王槐志. 腹腔镜胰十二指肠切除术主要并发症及处理[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(03): 215-218.
[6] 辛林璞, 杨敏, 杜峻峰. 腹腔镜结直肠癌根治术后常见并发症防治与管理[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(03): 248-251.
[7] 王兰, 杨雪, 聂阿娜, 郭伟林, 谷坤熙, 赵建红, 翟佳琪, 张伟, 李杨, 陈晓丽, 尚培中. 胰腺头部巨大实性假乳头状瘤行门静脉保留型非整块胰头十二指肠切除一例[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(03): 300-302.
[8] 孙备, 陈华. 腹腔镜胰十二指肠切除术[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(03): 219-219.
[9] 陈华, 孙备. 我国胰头癌腹腔镜胰十二指肠切除术难点与对策[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(05): 483-486.
[10] 李金洁, 颜迪, 高德山. 改良桥式导管内引流在腹腔镜胰十二指肠切除术中的应用研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(05): 488-491.
[11] 刘凌, 陈创华, 杨祺俊, 陆军, 董鑫. 阶梯式经皮胆道镜激光技术在胰十二指肠切除术后胆肠吻合口狭窄的应用[J/OL]. 中华腔镜外科杂志(电子版), 2026, 19(02): 94-99.
[12] 卓浚哲, 王敏. 胰十二指肠切除术微创治疗的研究进展与争议[J/OL]. 中华腔镜外科杂志(电子版), 2026, 19(01): 49-55.
[13] 公伟, 邓鑫, 徐帅, 王博文, 刘军. 老年患者腹腔镜胰十二指肠切除术后教科书结局及影响因素分析[J/OL]. 中华腔镜外科杂志(电子版), 2025, 18(06): 329-336.
[14] 周进原, 黄文涛, 朱海, 蓝天盛, 庞志勇, 毛伟民, 蒙柄成, 蓝祝晶, 徐邦浩, 文张. 成人胆总管囊肿癌变外科治疗单中心回顾性研究[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(05): 812-818.
[15] 弓欣艳, 于祥, 冀雨薇, 王宝龙, 张伟光, 冯哲. 老年下尿路症状的影响因素及其作用机理全景分析[J/OL]. 中华肾病研究电子杂志, 2025, 14(06): 331-338.
阅读次数
全文


摘要


AI
小
编
AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?